Gynaecological Cancers: Biology and Therapeutics

Gynaecological cancers are categorised as ‘rare’ diseases, although collectively they affect over 16,000 women each year in the UK alone. There is a lack of real understanding of these conditions compared with other malignancies, possibly owing to their relative rarity when viewed as individual diseases. The 60th RCOG Study Group brought together a range of experts to examine as many biological aspects of gynaecological cancers as possible, including both surgical and non-surgical therapies. This book presents the findings of the Study Group, with contents including: * current understanding of the biology of gynaecological cancers * translation of biology to the clinic * state of the art in imaging and therapy * current clinical trials * advances in multimodal therapy * individualised treatment.